|
CBWD2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.63119999999173E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.563300E-03 |
| Normal-vs-Stage2 |
1.779500E-03 |
| Normal-vs-Stage3 |
1.8038000004772E-07 |
| Normal-vs-Stage4 |
1.17549999956168E-07 |
| Stage1-vs-Stage2 |
3.576400E-01 |
| Stage1-vs-Stage3 |
1.923900E-03 |
| Stage1-vs-Stage4 |
1.319250E-03 |
| Stage2-vs-Stage3 |
1.756640E-01 |
| Stage2-vs-Stage4 |
8.782500E-02 |
| Stage3-vs-Stage4 |
6.301200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.26509999978752E-07 |
| Normal-vs-AfricanAmerican |
4.581000E-01 |
| Normal-vs-Asian |
5.465600E-01 |
| Caucasian-vs-AfricanAmerican |
4.401600E-04 |
| Caucasian-vs-Asian |
2.320800E-01 |
| AfricanAmerican-vs-Asian |
8.438600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.82769998924704E-09 |
| Normal-vs-Female |
2.073600E-02 |
| Male-vs-Female |
1.785230E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.84310000001165E-06 |
| Normal-vs-Age(41-60Yrs) |
1.956930E-04 |
| Normal-vs-Age(61-80Yrs) |
3.41589999997005E-06 |
| Normal-vs-Age(81-100Yrs) |
7.351700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.441000E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.174400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.583800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.039400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.659000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.028600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.546200E-01 |
| Normal-vs-Grade 2 |
1.735840E-03 |
| Normal-vs-Grade 3 |
2.0397999999977E-05 |
| Normal-vs-Grade 4 |
3.09799963460478E-10 |
| Grade 1-vs-Grade 2 |
5.608000E-01 |
| Grade 1-vs-Grade 3 |
2.410200E-01 |
| Grade 1-vs-Grade 4 |
4.160800E-03 |
| Grade 2-vs-Grade 3 |
9.638500E-02 |
| Grade 2-vs-Grade 4 |
4.72709999999044E-06 |
| Grade 3-vs-Grade 4 |
1.204350E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.878350E-03 |
| Normal-vs-ccB subtype |
5.88709969662204E-10 |
| ccA subtype-vs-ccB subtype |
1.76993999999597E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.55536999999484E-05 |
| Normal-vs-N1 |
4.78340000054089E-07 |
| N0-vs-N1 |
3.019900E-03 |
|
|
